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Abstract
We propose a new continuous-discrete mixture regression model which is useful for
describing highly censored data. We motivate our investigation based on a case-study in
biometry related to measles vaccines in Haiti. In this case-study, the neutralization antibody
level is explained by the type of vaccine used, level of the dosage and gender of the patient.
This mixture model allows us to account for excess of censored observations and consists
of the Birnbaum-Saunders and Bernoulli distributions. These distributions describe the
antibody level and the point mass of the censoring observations. We estimate the model
parameters with the maximum likelihood method. Numerical evaluation of the model is
performed by Monte Carlo simulations and by an illustration with biometrical data, both of
which show its good performance and its potential applications.
Keywords Bernoulli and Birnbaum-Saunders distributions; censoring; maximum likeli-
hood method; mixture distributions; Monte Carlo simulation; R software.
1 Bibliographical review and motivating example
In this section, we provide an introduction to the topic accompanied by a state of art about
studies linked to the present investigation. In addition, a motivating example from biometry is
presented to justify the development of the proposed methodology.
1.1 Introduction
A frequently studied topic in survival models is the censored data analysis. Particularly, to-
bit models are used to estimate parameters of interest when censored data are present; see Lee
∗Vı´ctor Leiva, Email: victorleivasanchez@gmail.com, URL: www.victorleiva.cl
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(1996) and Klein and Moeschberger (2003) for details on tobit models as well as censored and
truncated data, respectively. However, we detect three problems regarding the standard tobit
model. First, it has a strong assumption which is the normality (and therefore symmetry) for the
model error. Second, the standard tobit model does not cover situations of extreme heaviness for
the censored part of the distribution. Third, tobit models does not take into account the lower
detection limit (LDL) and the possible existence of some observations below this LDL. This
situation is present in studies of immunogenecity related to measles vaccine data; see details
in Section 1.2. Therefore, first, as it is well-known, ignoring the effect of asymmetry can be
harmful and lead to significantly biased estimates. Then, some flexible tobit models, in terms
of kurtosis and asymmetry, are been introduced by Martı´nez-Flores et al. (2013), Rocha et al.
(2015), Barros et al. (2018) and Desousa et al. (2018), but these tobit models do not solve sec-
ond and third problems.
A two-part model proposed by Cragg (1971) solves the problem of a large number of cen-
sored observations. That model considers the possibility of having observations from the as-
sumed distribution for data with positive support (part 1) and from a point mass distribution
(part 2). In the model, the log-normal (LN) distribution was considered for the positive response
variable. However, this model based on the LN distribution does not consider the existence of
both an LDL and some observations at or below this LDL. Moulton and Halsey (1995) pro-
posed a generalization of the two-part model, named Bernoulli/LN model, by considering the
possibility of limited responses resulting from interval censoring associated with the positive
support distribution. In the generalized two-part model, any value above the LDL obligatorily
comes from the LN distribution, whereas a censored value may come from either the point mass
distribution or the LN distribution.
The Birnbaum-Saunders (BS) distribution is unimodal, positively skewed and has a close
relation with the normal distribution, such as the LN distribution; see Birnbaum and Saunders
(1969), Johnson et al. (1995) and Leiva (2016). The BS distribution has two parameters related
to its shape and scale, where the latter one is also its median. Thus, the BS distribution can
be seen as an analogue to the normal distribution, but in an asymmetric setting, where the me-
dian is generally considered to be a better measure of central tendency than the mean. The BS
distribution has been applied to model business, engineering, environmental and industry data,
which have been conducted by international, transdisciplinary groups of researchers. Some
of its recent applications are attributed to Saulo et al. (2013), Santos-Neto et al. (2014, 2016),
Leiva et al. (2015, 2016a,b, 2017), Wanke and Leiva (2015), Marchant et al. (2016, 2018) and
Garcia et al. (2018a,b). The BS distribution has shown to be a good alternative to describe
medical data in the works by Lea˜o et al. (2017, 2018a). However and more relevantly, its ad-
equacy to model medical data was justified in the recently work by Lea˜o et al. (2018b) using
mathematical arguments based on a conceptual analogy between material fatigue and medical
settings.
The main objective of this paper is to propose a fixed-effect (regression) model for left-
censored data based on the mixture between the BS and Bernoulli distributions, that is, a skew
positive continuous distribution and a point mass distribution located below the LDL. The pro-
posed model extends the Bernoulli/LN model to the BS case. The secondary objectives of
this paper are: (i) to develop inference for the Bernoulli/BS model based on the maximum
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likelihood (ML) method; (ii) to perform a Monte Carlo (MC) simulation study to evaluate the
performance of the ML estimators; and (iii) to carry out an application of the proposed model
to an immunogenecity study of measles vaccine in Haiti. Thus, the Bernoulli/BS model appears
as a new alternative to describe censored data. In order to motivate our research, we describe
the following example with medical data related to immunogenecity.
1.2 Motivating example in biometry
Determination of antibody concentration by quantitative assays is an important topic of re-
search. In such a topic, often there is a concentration value (Vc) below which an exact mea-
surement cannot be obtained, regardless of the employed technique. However, this antibody
concentration value Vc is a function of the associated assay. When left-censoring is present in
data from an assay, the LDL can be used to substitute the value of the censored observation by
using Vc. In special, this substitution is applied to immunogenecity studies where data are often
censored. Then, tobit models could be used to estimate the parameters of interest. However,
statistical modeling for data analysis of this type are not yet fully disseminated and the topic is
still an object of discussion.
The motivation for our study came from a real-world medical data set provided byMoulton and Halsey
(1995) about a safety and immunogenecity study related to measles vaccines in Haiti. In this
case-study, the variable of interest (response) is the neutralization antibody level, whereas the
following explanatory variables (covariates) were considered to explain this response: (i) EZ is
the type of vaccine used (0 if Schwartz and 1 if Edmonston-Zagreb); (ii) HI is the level of the
dosage (0 if medium and 1 if high); and (iii) FEM is the gender (0 for male and 1 for female).
Then, a regression model could be used to describe the relationship between the response and
covariates. However, the response was observed in 330 children at 12 months of age, of which
86 (26.1%) cases had a neutralization antibody level below the LDL and then such levels were
recorded with the corresponding Vc. Note that in this study the LDL was Vc = 0.1, in inter-
national units, or −2.306 in logarithm scale. Therefore, a first natural approach for describing
these data can be the tobit model based on the normal distribution (tobit-normal); see details in
Barros et al. (2010) and Section 2.2. Figure 1(a) displays the QQ plot with simulated envelopes
of the generalized Cox-Snell (GCS) residual based on the tobit-normal model; see Section 3.4
for details about this residual. This figure shows that the GCS residuals provide a bad perfor-
mance of this first model fitted to measles vaccines data. We observe from this figure that the
bad fitting is detected mainly in the right tail. Therefore, a tobit model based on heavy-tailed
distribution, such as the t distribution, might improve the fitting. Then, we consider the tobit-t
model for this possible improvement. Figure 1(b) presents a similar plot to that Figure 1(a)
but now based on the tobit-t model; see Section 2.2 for details of this model. Once again, the
residual plots shows a bad performance now of the tobit-t model, so that we deduct the prob-
lem was not due to the right tail but to a posible asymmetry, because we have evaluated only
tobit-symmetric models. Next, an exploratory data analysis is conducted to detect asymmetry
and kurtosis.
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Figure 1: QQ plot and its envelope for the GCS residuals with the indicated model using vaccine data.
Table 1 provides descriptive statistics for the measles vaccine data set, including minimum,
maximum, median, mean, standard deviation (SD) and coefficients of variation (CV), skewness
(CS) and kurtosis (CK). The CK and CS indicate the positive skew nature and high kurtosis level
of the data distribution. Figure 2 shows the histogram and boxplots for the measles vaccine
data. From this figure, note that the skewed nature reported in Table 1 is confirmed by the
histogram of Figure 2(a). Note that some outliers considered by the usual boxplot presented
in Figure 2(b) are not outliers when we consider the adjusted boxplot; see details on this latter
boxplot in Rousseeuw et al. (2016). Then, under asymmetry, a heavy-tailed distribution is not
needed, but rather a positive skew distribution. Therefore, we consider tobit-LN and tobit-BS
models; see details about these models in Desousa et al. (2018). Figure 3(a) displays the QQ
plot with simulated envelopes of the GCS residual based on the tobit-LN and tobit-BS models.
This figure shows a better performance of the tobit-LN model in relation to the tobit-normal
and tobit-t models. However, the tobit-LN model is still inappropriate, but the tobit-BS model
seems to be appropriate, although some fitting problems are detected at the tails possibly due to
the extreme percentage of censoring.
Table 1: Descriptive statistics for vaccine data.
n Min Max Mean Median SD CV CS CK
330 0.10 15.47 1.20 0.40 2.10 174.74% 3.46 14.37
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Figure 2: Histogram (a) and boxplots (b) for vaccine data.
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Figure 3: QQ plot and its envelope for GCS residual with the indicated model using vaccine data.
In summary, it is necessary to consider a model to analyze measles vaccine data, which have
censoring and asymmetry. However, the model to be postulated must consider an LDL and
high censoring. As mentioned, tobit models do not consider this limit and its omission can
distort the results obtained from the corresponding analysis. Therefore, this example serves as a
motivation to formulate a model which allows us to describe high censoring, asymmetry and an
LDL. The model to be formulated should be based on a distribution with theoretical arguments
useful in biometry (as the BS distribution), to account for excess of censored observations and
to estimate a proportion that determines the contribution of the point mass distribution.
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1.3 Organization of the paper
The rest of the paper proceeds as follows. Section 2 provides a background of the BS dis-
tribution and its logarithmic transformation, as well as of tobit models and mixture models for
left-censored data. In Section 3, we formulate the Bernoulli/BS model along with inference
and estimation based on the ML method. In Section 4, the model is evaluated through MC
simulations and illustrated with biometrical data related to measles vaccines in Haiti. Some
concluding remarks and possible future research are mentioned in Section 5.
2 Preliminaries
In this section, we present a background related to (i) the BS distribution and its logarithmic
transformation; (ii) tobit models; and iii) mixture models for left-censored data.
2.1 BS and log-BS distributions
Let T be a random variable with BS distribution of shape (α) and scale (σ) parameters,
denoted it by T ∼ BS(α, σ). Then, the probability density function (PDF) of T is expressed as
fT (t;α, σ) =
1
2α
(√
1/σt+
√
σ/t
3
2
)
φ
(
1
α
(√
t/σ −
√
σ/t
))
, t > 0, α > 0, σ > 0, (1)
where φ is the standard normal PDF. When covariates (Xi) are added in a statistical modeling
based on the BS distribution with PDF as given in (1), the relation between the response variable
(Ti) and the observed values (xi) of these covariates is often non-linear with an exponential
structure, as usual in asymmetric data; see Marchant et al. (2016). Then, in order to formulate
fixed-effect models under a BS setting, one transforms the exponential regression structure to a
linear one of standard type as
Yi = x
⊤
i β + εi, i = 1, . . . , n, (2)
where Yi = log(Ti), x
⊤
i = (xi1, xi2, . . . , xip) is the ith observation on a set of p independent
covariatesXi, β
⊤ = (β1, β2, . . . , βp) is a vector of fixed effect parameters to be estimated, εi
is the error term of the model. Note that εi defined in (2) corresponds to εi = log(δi), where
δi ∼ BS(α, 1). Then, this modeling framework needs the use of a logarithmic version of the
BS distribution (log-BS) defined as follows. A random variable Y has a log-BS distribution
with shape (α > 0) and location (µ ∈ R) parameters, denoted it as log-BS(α, µ), if and only if
Z = (2/α)sinh((Y − µ)/2) ∼ N(0, 1), where µ = log(σ). Then, the cumulative distribution
function (CDF) of Y is given by
FY (y;α, µ) = Φ
(
2
α
sinh
(
y − µ
2
))
, y ∈ R, µ ∈ R, α > 0. (3)
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Consequently, from (3), the PDF of Y is defined as
fY (y;α, µ) =
1
α
√
2π
cosh
(
y − µ
2
)
exp
(
− 2
α2
sinh2
(
y − µ
2
))
, y ∈ R, µ ∈ R, α > 0, (4)
whereas the logarithm of the PDF given in (4) is expressed as
log(fY (y;α, µ)) = − log(2)− log(2π)
2
+ log
(
2
α
cosh
(
y − µ
2
))
− 2
α2
(
sinh
(
y − µ
2
))2
,
for y ∈ R, which is useful for several purpose, such as in likelihood-based methods.
2.2 Tobit models
Consider a sample of size n, Y = (Y1, . . . , Ym, Ym+1, . . . , Yn)
⊤ namely, composed by inde-
pendent (IND) random variables but not necessarily independent identically distributed (IID).
Consider also that this sample includes m censored data to the left and n − m complete or
uncensored data.
The tobit setting is formulated such that them censored data correspond to the values of Y ∗
(censored response) less than or equal to a threshold point ξ (censoring to the left), so that all
of these data take the value ξ. The remaining n − m uncensored data are related to values of
Y ∗ greater than ξ, which can be modeled by a linear regression structure. Then, the tobit model
with censored response to the left can be written as
Yi =
{
ξ, if Y ∗i ≤ ξ, i = 1, . . . , m;
x⊤i β + εi, if Y
∗
i > ξ, i = m+ 1, . . . , n,
(5)
where εi
IID∼ F , β and xi are as defined in (2). Table 2 reports some tobit models according to
the distribution F considered. Note that ξ given in (5) is a prefixed limiting value that makes
the response of the regression model to be censored. Figure 4 provides an illustration of the
tobit model presented in (5) when ξ = 0 with one covariate. Note that, when Y ∗i is less than
or equal to ξ = 0, Yi is equal to ξ = 0. The Tobit models use all of the information, including
censoring.
Table 2: Different tobit models according to the error distribution and its bibliographical refer-
ence.
Distribution (F ) Reference
Normal Tobin (1958)
LN Hsu and Liu (2008)
Student-t Barros et al. (2018)
BS Desousa et al. (2018)
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Figure 4: Illustration of the tobit model when ξ = 0.
2.3 Mixture models for highly censored data
Cragg (1971) proposed a formulation to account for highly censored data described by
g(yi) = πi1i + (1− πi)f(yi)(1− 1i), (6)
where 0 < πi < 1 is a weight factor that determines the contribution of the point mass distri-
bution, f is the LN PDF of a random variable Y and 1i is a function indicating the value 0 if
yi > Vc and 1 if yi ≤ Vc. Note that the PDF given in (6) is not restricted to a specific statistical
distribution, so that it can be switched by other models different to the LN one. However, the
framework presented in (6) does not consider the possibility of an LDL.
Moulton and Halsey (1995) extended the model proposed by Cragg (1971) to a generalized
version of two-parts considering limiting responses coming from interval censoring. This model
incorporates an intermediary possibility that a censored value may be from either f or from the
point mass distribution. The PDF for the generalized two-part model is given by
g(yi) = (πi + (1− πi)F (Vc)) 1i + (1− πi)f(yi)(1− 1i), (7)
where F is the CDF associated with the PDF f and its corresponding CDF is obtained as
G(yi) =

0, if yi ≤ 0;
πi + (1− πi)F (Vc), if 0 < yi ≤ Vc;
πi + (1− πi)F (Vc) + (1− πi)(F (yi)− F (Vc)), if yi > Vc.
Note that a wide family of mixture models can be created by changing f and the distribution
associated with πi in (7). For example, the mixture estructure can be modeled with a dichoto-
mous random variable B with Bernoulli distribution of parameter P(B = 1) = τ = 1 − π.
Martı´nez-Flo´rez et al. (2013) derived a Bernoulli/log-power-normal model. Note that if f cor-
responds to the N(x⊤i β, σ
2) distribution and πi = 0, for i = 1, . . . , n, the formulation given in
(7) for the generalized two-part model becomes the standard tobit model defined in (5). Never-
theless, as mentioned, the tobit setting is unable for modeling situations with excess of censored
observations nor the presence of a LDL for observations censored below this LDL.
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3 The Bernoulli/BS mixture model
In this section, we formulate the newmixture model. Then, we estimate its parameters by the
ML method. Details about inference for these parameters is also provided, as well as a residual
analysis as diagnostic tool for model checking.
3.1 Formulation
We propose a mixture model between the Bernoulli and BS distributions (Bernoulli/BS) by
assuming that f given in (7) corresponds to the log-BS PDF defined in (4) and πi associated
with the random variable B following a Bernoulli distribution of parameter 1 − πi. Then, the
formulation defined in (7) can be rewritten as follows
(8)
g(yi) =
(
πi + (1− πi) Φ
(
ζ c2i
))
1i
+ (1− πi)
(
c1
α
cosh
(
yi − µi
2
)
exp
(
− 2
α2
sinh2
(
yi − µi
2
)))
(1− 1i),
where c1 = 1/
√
2π, µi = x
⊤
(1)i
β(1), ζ
c
2i
= (2/α) sinh((Vc − x⊤(1)iβ(1))/2),
1i =
{
1, if y ≤ Vc;
0, if y > Vc;
(9)
Φ is the standard normal CDF, x(1) is a vector of values for covariates associated with the log-
response variable and β(1) is the corresponding fixed-effect parameters. For the parameter πi
associated with the random variable B earlier defined, we assume the logit link function
logit (P (B = 1|xi)) = x⊤(2)iβ(2) ⇐⇒ τi = 1− πi =
exp(x⊤(2)iβ(2))
1 + exp(x⊤(2)iβ(2))
, (10)
where x(2) are observed covariates related to fixed-effect parameters β(2) of the link function.
3.2 Estimation
Combining expressions (8) and (10), we obtain the individual contribution to the likelihood
function of parameter θ = (α,β⊤(1),β
⊤
(2))
⊤ of the mixture Bernoulli/BS model that is given by
Li(θ) =
(
1 +
exp(x⊤(2)iβ(2))
1 + exp(x⊤(2)iβ(2))
(
Φ
(
ζ c2i
)− 1))1i
×
(
exp(x⊤(2)iβ(2))
1 + exp(x⊤(2)iβ(2))
(
c1
α
cosh
(
yi − µi
2
)
exp
(
− 2
α2
sinh2
(
yi − µi
2
))))1−1i
,
(11)
where c1, µ and ζ
c
2i
are as given in (8) and 1i in (9).
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The log-likelihood function for θ = (α,β⊤(1),β
⊤
(2))
⊤ obtained by taking the logarithm of (11)
is expressed as
(12)
ℓ(θ) = −(n−m) log(2)− (n−m) log(2π)
2
+
n∑
i=1
1i
(
log
(
1 + exp(x⊤(2)iβ(2))Φ (ζ
c
i2)
)− log (1 + exp (x⊤(2)iβ(2))))
+
n∑
i=1
(1− 1i)
(
x⊤(2)iβ(2) + log (ζ1i)−
1
2
ζ22i − log
(
1 + exp(x⊤(2)iβ(2))
))
,
where ζ c2i is as given in (8) and
ζ1i =
2
α
cosh
(
yi − x⊤(1)iβ(1)
2
)
, ζ2i =
2
α
sinh
(
yi − x⊤(1)iβ(1)
2
)
. (13)
To obtain the ML estimators, it is necessary to maximize the log-likelihood function given in
(12). The corresponding score vector is defined as ℓ˙ = ∂ℓ(θ)/∂θ = (ℓ˙α, ℓ˙
⊤
β(1)
, ℓ˙⊤β(2))
⊤, which
contains the first partial derivatives of (12), where
ℓ˙α =

− 1
α
(
exp(x(2)iβ(2))φ(ζ
c
2i
)ζ c2i
1 + exp
(
x(2)iβ(2)
)
Φ(ζ c2i)
)
, i = 1, . . . , m;
1
α
(ζ22i − 1), i = m+ 1, . . . , n;
ℓ˙β(1) =

−x(1)i
2
(
exp(x(2)iβ(2))φ(ζ
c
2i
)ζ c1i
1 + exp(x(2)iβ(2))Φ(ζ
c
2i
)
)
, i = 1, . . . , m;
x(1)i
2
(
ζ1iζ2i −
ζ2i
ζ1i
)
, i = m+ 1, . . . , n;
(14)
ℓ˙β(2) =
x(2)i
(
exp(x(2)iβ(2))Φ(ζ
c
2i
)
1 + exp(x(2)iβ(2))Φ(ζ
c
2i
)
− τi
)
, i = 1, . . . , m;
x(2)i(1− τi)), i = m+ 1, . . . , n,
where ζ1i and ζ2i are given by equation (13), with ζ
c
1i
and ζ c2i being similarly given as in (13)
but using τi instead of yi. The ML estimator of θ is obtained equating (14) to zero . Note that
the system of equations defined by ℓ˙α = 0, ℓ˙β(1) = 0 and ℓ˙β(2) = 0 does not have an analytic
solution. In this paper, we solve them by an iterative procedure for non-linear optimization
known ad Broyden-Fletcher-Goldfarb-Shanno (BFGS) quasi-Newton method.
3.3 Inference
Considering that some regularity conditions discussed in Cox and Hinkley (1974) hold, the
ML estimators α̂, β̂(1) and β̂(2) are consistent and follow a multivariate normal joint asymptotic
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distribution with mean θ and covariance matrixΣθ̂ = J (θ)−1, that is, as n→∞, we have that
√
n(θ̂ − θ) d→ Np+1
(
0p+1,J (θ)−1
)
,
where
d→ means “convergence in distribution to”, J (θ) = lim
n→∞
(1/n)I(θ), with I(θ) being
the expected Fisher information matrix. Notice that Î(θ)−1 is a consistent estimator of the
asymptotic variance-covariance matrix of θ̂. However, in practice, we may approximate the
expected Fisher information matrix by its observed version (Efron and Hinkley, 1978), which
can be obtained from the Hessian matrix. Furthermore, the corresponding standard errors (SEs)
may be approximated by using the diagonal elements of its inverse. The corresponding Hessian
matrix is given by
ℓ¨ =
 tr(G) k⊤(1)x(1) k⊤(2)x(2)x⊤(1)k(1) x⊤(1)V(1)x(1) x⊤(1)Dx(2)
x⊤(2)k(2) x
⊤
(2)Dx(1) x
⊤
(2)V(2)x(2)
 ,
where
V(1) = diag{v(1)1(θ), v(1)2(θ), v(1)3(θ), . . . , v(1)n(θ)},
V(2) = diag{v(2)1(θ), v(2)2(θ), v(2)3(θ), . . . , v(2)n(θ)},
k(1) = (k(1)1(θ), k(1)2(θ), k(1)3(θ), . . . , k(1)n(θ))
⊤,
k(2) = (k(2)1(θ), k(2)2(θ), k(2)3(θ), . . . , k(2)n(θ))
⊤,
D = diag{d1(θ), d2(θ), d3(θ), . . . , dn(θ)},
G = diag{g1(θ), g2(θ), g3(θ), . . . , gn(θ)},
with
gi(θ) =

1
α2
(
exp
(
x⊤
(2)i
β(2)
)
φ(ζc2i
)ζc1i(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
) +
ζ2c2i
φ(ζc2i
) exp
(
x⊤
(2)i
β(2)
)
(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)
)
− 1
α2
(
φ2(ζc2i
)ζ2c2i
exp
(
2x⊤
(2)i
β(2)
)
(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)
)
, i = 1, . . . , m;
− 1
α2
(3ζ22i − 1), i = m+ 1, . . . , n;
k(1)i(θ) =

exp
(
x⊤
(2)i
β(2)
)
2α
(
ζc1i
φ(ζc2i)+ζ
c
1i
φ(ζc2i)ζ
2c
2i(
1+exp
(
x⊤
(2)i
β(2)
)
(Φ(ζc2i)−1)
) +
exp
(
x⊤
(2)i
β(2)
)
φ2(ζc2i)ζ
c
1i
ζc2i(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)2
)
, i = 1, . . . , m;
1
α
(ζ1iζ2i), i = m+ 1, . . . , n;
k(2)i(θ) =
−
exp
(
x⊤
(2)i
β(2)
)
φ(ζc2i
)ζc2i
α
((
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)
−1
(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)2
)
, i = 1, . . . , m;
0, i = m+ 1, . . . , n;
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di(θ) =
−
1
2
(
exp
(
x⊤
(2)i
β(2)
)
φ(ζc2i
)ζc1i(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
) − exp
(
2x⊤
(2)i
β(2)
)
φ(ζc2i
)ζc1i
Φ(ζc2i
)
(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)2
)
, i = 1, . . . , m;
0, i = m+ 1, . . . , n;
v(1)i(θ) =

exp
(
x⊤
(2)i
β(2)
)
4
(
−φ(ζc2i
)ζc2i
+ζ2c1i
ζc2i
φ(ζc2i
)(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
) +
φ2(ζc2i
)ζ2c1i
exp
(
x⊤
(2)i
β(2)
)
(
1+exp
(
x⊤
(2)i
β(2)
)
Φ(ζc2i
)
)2
)
, i = 1, . . . , m;
1
4
(1− (ζ22i/ζ21i)− ζ21i − ζ22i), i = m+ 1, . . . , n,
v(2)i(θ) =

exp
(
x⊤
(2)i
β(2)
)
(Φ(ζc2i)−1)(
1+exp(x⊤
(2)i
β(2))(Φ(ζc2i)−1)
) −
(
exp
(
x⊤
(2)i
β(2)
)
(Φ(ζc2i)−1)
)2
(
1+exp
(
x⊤
(2)i
β(2)
)
(Φ(ζc2i)−1)
)2 − τi + τ 2i , i = 1, . . . , m;
τi − τ 2i , i = m+ 1, . . . , n.
3.4 Residual analysis
We consider the GCS residual to assess goodness of fit and departures from the assumptions
of the model. This residual is often used in generalized linear models and survival analysis. The
GCS residual is given by
rGCSi = − log (Ŝ(yi; θ̂)), i = 1, . . . , n,
where S is the corresponding survival function fitted to the data. If the model is correctly
specified, then the GCS residual has a unit exponential distribution, EXP(1) in short.
4 Numerical studies
In this section, we provide the numerical results of our study. First, we evaluate the perfor-
mance of the new mixture model through MC simulations. Then, an illustration of this model
is presented with the biometrical data related to the case study of Section 1.2.
4.1 Simulation study
We present an MC simulation study with 5000 replications that intends to reveal the perfor-
mance of the ML estimators for the parameters of the Bernoulli/BS model. The sample sizes
considered are n = 100, 300, 500, with parameters α = 0.1, 0.5, 1, 2, 4,β(1) = (0.2, 0.5)
⊤ and
β(2) = (1, 2)
⊤. We consider one covariateX , whereX ∼ Uniform(0, 1). The generated values
for the response variable were obtained as follows
Ti =
{
1, with probability 1− exp(β(2)0+β(2)1xi)
1+exp(β(2)0+β(2)1xi)
,
exp (β(1)0 + β(1)1xi) δi, with probability
exp(β(2)0+β(2)1xi)
1+exp(β(2)0+β(2)1xi)
,
where δi ∼ BS(α, 1). In order to obtain Yi we take the natural logarithm of Ti.
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We compute the empirical mean, bias and mean squared error (MSE) in order to evaluate
the performances of the estimators. All numerical evaluations were done in the R software; see
R Core Team (2016). Table 3 presents theML estimation results obtained for the mentioned val-
ues of sample sizes and parameters. This table allows to conclude that, for α = 0.1, 0.5, 1.0, 2.0,
as the sample size increases, the bias and MSE of all estimators decrease, as expected. In gen-
eral, the results show the good performance of the ML estimators of the Bernoulli/BS model
parameters.
Table 3: Summary statistics from simulated Bernoulli/BS data for the indicated estimator and
sample size.
α θ
n = 100 n = 300 n = 500
Mean Bias MSE Mean Bias MSE Mean Bias MSE
0.1 α 0.21103 0.11103 0.62099 0.14891 0.04891 0.00328 0.10005 0.00005 0.00039
β(1)0 = 0.2 0.21215 0.01215 1.03058 0.20326 0.00326 0.08643 0.20309 0.00309 0.01018
β(1)1 = 0.5 0.48652 −0.01348 0.98195 0.50374 0.00374 0.09117 0.50057 0.00057 0.00977
β(2)0 = 1 1.00140 0.00140 1.17457 1.00115 0.00115 0.08867 0.99797 −0.00203 0.00997
β(2)1 = 2 1.98399 −0.01600 1.04944 2.00469 0.00469 0.09159 2.00104 0.00104 0.01007
0.5 α 0.50211 0.00211 0.01549 0.49848 −0.00152 0.00343 0.50004 0.00004 0.00032
β(1)0 = 0.2 0.22839 0.02839 0.81110 0.21216 0.01216 0.14482 0.20293 0.00293 0.00919
β(1)1 = 0.5 0.49694 −0.00306 0.79049 0.50993 0.00993 0.15961 0.50054 0.00054 0.00881
β(2)0 = 1 1.00613 0.00613 0.83217 1.01332 0.01332 0.17506 0.99807 −0.00192 0.00899
β(2)1 = 2 1.98798 −0.01201 0.81395 2.01255 0.01255 0.16855 2.00098 0.00098 0.00908
1 α 0.99855 −0.00145 0.06463 0.99941 −0.00059 0.00279 1.00004 0.00005 0.00039
β(1)0 = 0.2 0.30713 0.10713 0.46320 0.20529 0.00529 0.03719 0.20278 0.00278 0.00825
β(1)1 = 0.5 0.54346 0.04346 0.46502 0.50423 0.00423 0.03999 0.50052 0.00052 0.00791
β(2)0 = 1 1.09830 0.09830 0.64609 1.00368 0.00368 0.04167 0.99817 −0.00183 0.00807
β(2)1 = 2 2.04050 0.04050 0.54142 2.00462 0.00462 0.04132 2.00093 0.00093 0.00815
2 α 2.01445 0.01445 0.06145 1.99856 −0.00144 0.00159 2.00002 0.00002 0.00010
β(1)0 = 0.2 0.35064 0.15064 0.27488 0.20109 0.00109 0.00959 0.20030 0.00030 0.00010
β(1)1 = 0.5 0.56994 0.06994 0.24613 0.50125 0.00125 0.01012 0.50057 0.00006 0.00010
β(2)0 = 1 1.20834 0.20834 0.72936 1.00040 0.00040 0.00985 0.99979 −0.00021 0.00010
β(2)1 = 2 2.10056 0.10056 0.38308 2.00157 0.00157 0.01018 2.00010 0.00010 0.00010
4 α 5.74480 1.74480 31.44706 5.63512 1.63512 18.12119 4.21585 0.21585 4.01609
β(1)0 = 0.2 0.84559 0.64559 3.61015 0.90587 0.70587 3.46159 0.26577 0.06577 0.36885
β(1)1 = 0.5 0.77905 0.27905 0.90060 0.91386 0.41386 1.16450 0.53409 0.03409 0.10023
β(2)0 = 1 3.18593 2.8593 40.9525 3.29328 2.29328 34.75177 1.22581 0.22581 4.40974
β(2)1 = 2 3.09786 1.09786 10.54635 3.22245 1.22245 9.94170 2.10635 0.10635 0.97295
4.2 Illustrative example
We illustrate the proposed methodology by applying it to the real-world biometry data set
described in Section 1.2. Here, we present the estimation and checking results for the proposed
Bernoulli/BS model with these data. For comparison, the results of the standard tobit, in addi-
tion to the tobit-BS model, are given as well. The Bernoulli/BS model has a logit link function
with the same covariates used in the continuous component. Table 4 shows the ML estimates,
computed by the BFGS method, SEs, p-values of the t-test and the Akaike (AIC) information
(BIC) criterion. From this table, note that the Bernoulli/BS model provides better adjustment
compared to the other models based on the value of AIC. Figure 5 displays the QQ plots with
simulated envelope of the GCS residual. This figure shows that the GCS residuals provide an
excellent agreement with the EXP(1) distribution for the Bernoulli/BS models.
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Table 4: ML estimates (with SE in parentheses) and AIC values for the indicated models with
vaccine data.
Model AIC
Logit component Continuous component
Constant EZ HI FEM α Constant EZ HI FEM
Tobit 1299.27 2.573 0.597** 0.225 −0.228 0.271
(0.047) (0.288) (0.297) (0.295) (0.296)
Tobit-BS 1168.60 1.545 −0.910*** 0.188* 0.074 0.121
(0.048) (0.105) (0.111) (0.109) (0.110)
Bernoulli/BS 1085.32 0.762*** 0.739*** 0.347 −0.269 1.208 −0.061 −0.159 −0.180 0.284**
(0.245) (0.282) (0.270) (0.271) (0.064) (0.136) (0.143) (0.143) (0.144)
*10% of significance,** 5% of significance and ***1% of significance.
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Figure 5: QQ plot and its envelope for the GCS residual with the indicated model using vaccine data.
We note that, in the fitted Bernoulli/BS model presented in Table 4, only the variable FEM
is significant for the continuous component, whereas for the logit component only the variable
EZ was significant. Therefore, for the Bernoulli/BS model, the fitted final model is given by
π̂i =
1
1 + exp(0.762
(0.162)
+ 0.657
(0.260)
× EZ) and µ̂i = −0.146(0.089) + 0.233(0.129) × FEM,
with α̂ = 1.166 (0.053). A glance at these results indicate that, receipt of Edmonston-Zagreb
strain vaccine is related with an increase exp(0.657) = 1.193 in the odds ratio of being above the
detection limit. Moreover, the Bernoulli/BS model suggests that girls have exp(0.233) = 1.263
greater concentration of measles antibody than boys.
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5 Concluding remarks and future research
We have introduced a new continuous-discrete mixture fixed-effect model whose continuous
part follows a Birnbaum-Saunders distribution and its discrete-part a Bernoulli distribution.
This model is very flexible and useful for highly censored data. Our investigation was based
on a biometrical case-study related to measles vaccines in Haiti. We have performed estimation
and inference based on the maximum likelihood method. A Monte Carlo simulation study has
shown the good performance of the maximum likelihood estimators. The numerical results of
the case-study have proved the excellent agreement between the Bernoulli/Birnbaum-Saunders
model and the data, improving the fitting in relation to other competitors as the standard tobit
and tobit-BS models.
As part of further research, it is of interest to discuss influence diagnostic tools with more
detail and depth to detect globally and locally influential cases. This will allow us to evaluate
changes in the model’s significance and consequently in the medical decisions. In addition,
multivariate models can also be explored. Work on some of these issues is currently in progress
and we hope to report some findings in future papers.
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